The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
New Approach to Colorectal Surgical Care Speeds Recovery and Lowers Costs
According to research published online in theJournal of the American College of Surgeons, a new multidisciplinary approach to managing patients' post-colorectal surgery recovery results in shorter hospital stays, fewer complications, and lower medical costs.
Unexpected Weight Gain Post Fecal Matter Transplant
A woman successfully treated with fecal microbiota transplantation (FMT) for recurrent Clostridium difficile(C. difficile) from an overweight donor's stool found herself quickly gaining weight afterward to the point of obesity, reported a case published in the journal Open Forum Infectious Diseases.
Smoking Linked to Higher Risk of Death among Colorectal Cancer Survivors
Colorectal cancer survivors who smoke cigarettes were found to face more than twice the risk of death than non-smoking survivors, corroborating existing evidence that cigarette smoking is associated with colorectal cancer-specific mortality.
Clinicians Encouraged To Discuss Sexual Function with IBD Patients
While many women (and men) with inflammatory bowel disease (IBD) have experienced some level of sexual dysfunction, according to recent data, only less than one in 10 female patients revealed their physicians speak with them about this issue.
New Minimally Invasive Test IDs Patients for Barrett's Esophagus Screening
A new minimally invasive cell sampling device, Cytosponge-TFF3, coupled with assessment of trefoil factor 3 expressions, can successfully identify patients with reflux symptoms who warrant endoscopy to diagnose Barrett's esophagus.
AbbVie Wins European Approval for Hepatitis C Treatment
February 1st 2015Following similar approvals in the United States and Canada, AbbVie has been granted marketing authorization by the European Commission for an all-oral, interferon-free combination drug for the treatment of genotypes 1 and 4 chronic hepatitis C infection.
Steroid Therapy: Increasing Risk of Blood Clots 5-fold in IBD Patients
Corticosteroid (steroid) is associated with an approximately 5-fold increase of venous thromboembolism in patients suffering from inflammatory bowel disease (IBD), according to a new study published in Clinical Gastroenterology and Hepatology.
Potential Discovery of Pancreatic Cancerous Cell Mechanisms
January 28th 2015Researchers at Huntsman Cancer Institute (HCI) at the University of Utah recently discovered the mechanism potentially triggering pancreatic cancer from the defects resulting from extrusion, the process through which cells are squeezed out of overcrowded tissue to die.
Debating Testing or Treatment for Gastroparesis Part 2
As part of the American Gastroenterological Association's Winter Postgraduate Course, William D. Chey, MD, AGAF, from the University of Michigan, and Michael Camilleri, MD, AGAF, from the Mayo Clinic, discussed the best treatment course for patients with gastroparesis.
Debating Testing or Treatment for Gastroparesis
As part of the American Gastroenterological Association's Winter Postgraduate Course, William D. Chey, MD, AGAF, from the University of Michigan, and Michael Camilleri, MD, AGAF, from the Mayo Clinic, discussed the best treatment course for patients with gastroparesis.
Hepatitis C: What Therapy this Week?
"We really have entered this new era of direct acting antivirals, and as of this fall, we've finally laid to rest interferon in the grave that we've all been wanting to put it in, for more than 2 decades," said Jacqueline G. O'Leary, MD, MPH, during her presentation at the 2015 AGA Clinical Congress of Gastroenterology & Hepatology.
Meeting the Challenges of Value Demonstration in GI Practice
"There are only 2 or 3 things I know for sure. Only 2 or 3 things. That's right. Of course, it's never the same things, and I'm never as sure as I'd like to be," nuggets of wisdom (from the novel "Bastard Out of Carolina," by Dorothy Allison) that Thomas Murray, Senior Director of Quality Measurement & Improvement, AGA, shared at the 2015 AGA Clinical Congress of Gastroenterology & Hepatology.